Rubella vaccine trials in adults and children. Comparison of three attenuated vaccines.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001831:Body Temperature; D002021:Buffers; D002648:Child; D002986:Clinical Trials as Topic; D003168:Complement Fixation Tests; D046508:Culture Techniques; D004171:Diploidy; D004372:Ducks; D004622:Embryo, Mammalian; D004625:Embryo, Nonmammalian; D005076:Exanthema / Q000453:epidemiology; D005260:Female; D005347:Fibroblasts; D005998:Glycine; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007668:Kidney; D008198:Lymph Nodes / Q000276:immunology; D008722:Methods; D008875:Middle Aged; D009437:Neuralgia / Q000453:epidemiology / Q000209:etiology; D012141:Respiratory Tract Infections / Q000209:etiology; D012409:Rubella / Q000276:immunology*; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus / Q000302:isolation & purification; D013997:Time Factors; D014556:Urine / Q000382:microbiology; D014611:Vaccination; D014765:Viral Vaccines; D014776:Virus Cultivation
D000906:Antibodies; D002021:Buffers; D012411:Rubella Vaccine; D014765:Viral Vaccines; D005998:Glycine